A dual antagonist of 5-HT2A and σ2 receptors
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
CYR-101 is a dual antagonist of the serotonin (5-HT) receptor subtype 5-HT2A and sigma-2 (σ2) receptors (Kis = 7.53 and 8.19 nM, respectively).1
1.Davidson, M., Saoud, J., Staner, C., et al.Efficacy and safety of MIN-101: A 12-week randomized, double-blind, placebo-controlled trial of a new drug in development for the treatment of negative symptoms in schizophreniaAm. J. Psychiatry174(12)1195-1202(2017)
没有评价数据